BridgeBio Pharma, Inc. (BBIO)
74.95
+4.22
(+5.97%)
USD |
NASDAQ |
Oct 30, 16:00
74.74
-0.21
(-0.28%)
Pre-Market: 20:00
BridgeBio Pharma 30-Day Average Daily Volume : 2.958M for Oct. 30, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 30, 2026 | 2.958M |
| October 29, 2026 | 2.903M |
| October 28, 2026 | 2.816M |
| October 27, 2026 | 2.872M |
| October 26, 2026 | 2.937M |
| October 23, 2026 | 2.930M |
| October 22, 2026 | 2.909M |
| October 21, 2026 | 2.918M |
| October 20, 2026 | 2.895M |
| October 19, 2026 | 2.874M |
| October 16, 2026 | 2.849M |
| October 15, 2026 | 2.817M |
| October 14, 2026 | 2.783M |
| October 13, 2026 | 2.741M |
| October 12, 2026 | 2.720M |
| October 09, 2026 | 2.724M |
| October 08, 2026 | 2.697M |
| October 07, 2026 | 2.642M |
| October 06, 2026 | 2.622M |
| October 05, 2026 | 2.536M |
| October 02, 2026 | 2.521M |
| October 01, 2026 | 2.501M |
| September 30, 2026 | 2.492M |
| September 29, 2026 | 2.489M |
| September 28, 2026 | 2.462M |
| Date | Value |
|---|---|
| September 25, 2026 | 2.466M |
| September 24, 2026 | 2.439M |
| September 23, 2026 | 2.390M |
| September 22, 2026 | 2.370M |
| September 21, 2026 | 2.342M |
| September 18, 2026 | 2.308M |
| September 17, 2026 | 2.212M |
| September 16, 2026 | 2.215M |
| September 15, 2026 | 2.112M |
| September 14, 2026 | 2.024M |
| September 11, 2026 | 2.034M |
| September 10, 2026 | 2.059M |
| September 09, 2026 | 2.037M |
| September 08, 2026 | 2.032M |
| September 04, 2026 | 2.035M |
| September 03, 2026 | 2.053M |
| September 02, 2026 | 2.067M |
| September 01, 2026 | 2.065M |
| August 31, 2026 | 2.063M |
| August 28, 2026 | 2.053M |
| August 27, 2026 | 2.037M |
| August 26, 2026 | 2.120M |
| August 25, 2026 | 2.128M |
| August 24, 2026 | 2.171M |
| August 21, 2026 | 2.246M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.861M |
| Ionis Pharmaceuticals, Inc. | 3.114M |
| Pfizer Inc. | 30.18M |
| Cytokinetics, Inc. | 1.850M |
| Vertex Pharmaceuticals, Inc. | 1.263M |